NeuroSense Therapeutics L... (NRSN)
1.02
-0.01 (-0.97%)
At close: Jan 15, 2025, 1:38 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -11.28M | -12.34M | -4.04M | -2.83M | -1.22M |
| Depreciation & Amortization | 97.00K | 89.00K | 3.00K | 3.00K | n/a |
| Stock-Based Compensation | 1.54M | 5.11M | 4.16M | 2.06M | 611.00K |
| Other Working Capital | 928.00K | 291.00K | 289.00K | 37.00K | 6.00K |
| Other Non-Cash Items | 1.30M | -1.19M | 791.00K | -2.00K | 591.00K |
| Deferred Income Tax | -2.01M | n/a | -2.72M | 2.00K | n/a |
| Change in Working Capital | 1.91M | 750.00K | 273.00K | 69.00K | 29.00K |
| Operating Cash Flow | -8.45M | -7.59M | -1.54M | -695.00K | -582.00K |
| Capital Expenditures | -29.00K | -70.00K | -17.00K | -9.00K | -7.00K |
| Acquisitions | 3.00K | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | -3.50M | n/a | n/a | -19.00K |
| Sales Maturities Of Investments | 3.50M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -6.00K | 29.00K | n/a | n/a | -19.00K |
| Investing Cash Flow | 3.47M | -3.54M | -17.00K | -9.00K | -26.00K |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -75.00K | 3.69M | 2.04M | n/a | -3.00K |
| Financial Cash Flow | 3.90M | 3.69M | 11.90M | 508.00K | 1.42M |
| Net Cash Flow | -903.00K | -7.52M | 10.36M | -196.00K | 809.00K |
| Free Cash Flow | -8.48M | -7.66M | -1.56M | -704.00K | -589.00K |